Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Endometrial Neoplasms 2Urinary Bladder Neoplasms 1Sarcoma, Ewing 1Recurrence 1Rectal Diseases 1Pancreatic Neoplasms 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Intestinal Neoplasms 1Intestinal Diseases 1Graft vs Host Disease 1Glioblastoma 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Cancer With Liver Metastases 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1

Interventions

durvalumab 3abemaciclib 2Pemetrexed 2Fulvestrant 2Cisplatin 2Carboplatin 2ribociclib 1repotrectinib 1pembrolizumab 1palbociclib 1exemestane 1elacestrant 1cemiplimab 1atezolizumab 1Tamoxifen 1STX-478 1RAD1901 1Nivolumab 1Metformin 1Letrozole 1Immunotherapy 1Imlunestrant 1Drug Therapy 1Docetaxel 1Bevacizumab 1Anastrozole 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × Drug Therapy × 30 days × Clear all
NCT07222800 2026-06-04

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Pfizer

Phase 3 Recruiting
800 enrolled
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡